Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Sommet BFM patrimoine/CNCGP – Gay-Lussac Gestion | Louis de FELS, MD, Gay-Lussac Gestion SAAS OF 30 JUN 2023
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Louis De FELS is the MD of Gay-Lussac Gestion
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
currently manages approximately $1.3 billion in assets within its hedge fund portfolios|Paul Ernst, Managing Director,Sandler Capital Management
00:00:00
Alyx B. Porter, M.D. Neurologist, Mayo Clinic / Are all brain tumors cancerous : Ask Mayo Clinic
00:10:00
Advancing the Hawkins Gold Project in North Central Ontario
00:10:00
Understanding Active External Engagement: AXA IM for Progress Monitor - Olivier Eugene
00:10:00
Democratizing Private Markets for Retail Investors
00:10:00
"Mastering Investment Insight: Strategies, Psychology, and Organizational Success | Amy Edmondson at Norges Bank Investment Management's Annual Investment Conference 2024"
00:10:00
SNNLive interviews Brian Balbirnie, President and CEO of Issuer Direct Corporation (NYSE American: ISDR), at the company's headquarters in Raleigh, NC, discussing their communication and compliance services for corporate issuers.|Brian Balbirnie, Presiden
00:10:00
Scott Williamson Managing Director of Blackstone Minerals Ltd.
00:10:00
Christopher Joye's Macro Outlook at the 2024 Pinnacle Investment Summit | Christopher Joye - Founder and Chief Investment Officer of Coolabah Capital
00:10:00
Investment Strategies in Asia: Weijian Shan on US-China Relations and Key Career Learnings | Weijian Shan, CEO, PAG.
00:10:00
Initiator Pharma's presentation at Erik Penser Bank discusses biotechnology advancements, while Professor Peter Schantz explores how nature influences human health through GIH research.
00:10:00
Performance and Strategy Insights: Alliance Trust in 2023 | Craig Baker, CIO , Alliance Trust.